AI Sweden welcomes Emma Lennartsson, Regional Director, Stockholm Region and Markus Lingman, Chief Medical Intelligence Officer, Sahlgrenska University Hospital, to the AI Sweden Steering Committee.
![]()
The record-fast technological shift creates many opportunities, but also risks. Most important for the responsible use of AI is that we remain curious and ensure that we continuously learn more about AI's capabilities and limitations. In this way, we can ensure the responsible use of AI. AI Sweden has a very important role to play here for society as a whole, and I look forward to contributing to the steering committee's work.
![]()
Emma Lennartsson
Regional Director, Stockholm Region
![]()
We are in the midst of a societal transformation that operates across the entire spectrum, from geopolitics to the everyday life of the individual. It is crucial that we shape it together, especially in healthcare, where AI impacts lives.
![]()
Markus Lingman
Chief Medical Intelligence Officer, Sahlgrenska University Hospital
The current steering committee was elected during the Partner Forum in June, 2026. The steering committee members will serve for one year at a time. These are the current members of the steering committee:
(Chair) Peder Blomgren, VP/Head of Data Office, R&D, AstraZeneca
Magnus Hedberg, CEO, Akavia
Niklas Wahlberg, VP System Solutions and Partnerships, AB Volvo
Petter Bedoire, CTO, Saab
Ingrid Petersson, Chairperson, Lunds Universitet
Linus Wallin, MD, Atea Sweden
Charlotte Bergqvist, Chief Projects Officer, Country Manager Sweden, Cloudberry Clean Energy
Emma Lennartsson, Regional Director, Stockholm Region (NEW)
Markus Lingman, Chief Medical Intelligence Officer, Sahlgrenska University Hospital (NEW)
During AI Sweden's Partner Forum, it was also decided that Birgitta Bergvall-Kåreborn and Gunilla Nordlöf would conclude their terms on the board.